DE3785167T2 - Eine fluessige verabreichungsform fuer orale verabreichung einer pharmazeutischen substanz. - Google Patents

Eine fluessige verabreichungsform fuer orale verabreichung einer pharmazeutischen substanz.

Info

Publication number
DE3785167T2
DE3785167T2 DE8787850382T DE3785167T DE3785167T2 DE 3785167 T2 DE3785167 T2 DE 3785167T2 DE 8787850382 T DE8787850382 T DE 8787850382T DE 3785167 T DE3785167 T DE 3785167T DE 3785167 T2 DE3785167 T2 DE 3785167T2
Authority
DE
Germany
Prior art keywords
oral administration
pharmaceutical substance
administrative
liquid
liquid administrative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787850382T
Other languages
English (en)
Other versions
DE3785167D1 (de
Inventor
Kjell Johan Mattsson
Alf Gunnar Martin Nicklasson
Rolf Ivar Sjoeqvist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Application granted granted Critical
Publication of DE3785167D1 publication Critical patent/DE3785167D1/de
Publication of DE3785167T2 publication Critical patent/DE3785167T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
DE8787850382T 1986-12-22 1987-12-07 Eine fluessige verabreichungsform fuer orale verabreichung einer pharmazeutischen substanz. Expired - Lifetime DE3785167T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8605515A SE8605515D0 (sv) 1986-12-22 1986-12-22 A liquid dosage form for oral administration of a pharmaceutically active substance

Publications (2)

Publication Number Publication Date
DE3785167D1 DE3785167D1 (de) 1993-05-06
DE3785167T2 true DE3785167T2 (de) 1993-07-15

Family

ID=20366721

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787850382T Expired - Lifetime DE3785167T2 (de) 1986-12-22 1987-12-07 Eine fluessige verabreichungsform fuer orale verabreichung einer pharmazeutischen substanz.

Country Status (17)

Country Link
US (1) US5085868A (de)
EP (1) EP0273890B1 (de)
JP (1) JP2778030B2 (de)
AT (1) ATE87471T1 (de)
AU (1) AU609753B2 (de)
CA (1) CA1317883C (de)
DE (1) DE3785167T2 (de)
DK (1) DK668787A (de)
ES (1) ES2039480T3 (de)
FI (1) FI94923C (de)
GR (1) GR3007542T3 (de)
HK (1) HK66396A (de)
IE (1) IE60149B1 (de)
IL (1) IL86607A (de)
NO (1) NO177177C (de)
PH (1) PH25287A (de)
SE (1) SE8605515D0 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476447A (en) * 1968-03-28 1969-11-04 Westinghouse Electric Corp Self-aligning hydrostatic bearing
IE59934B1 (en) * 1987-06-19 1994-05-04 Elan Corp Plc Liquid suspension for oral administration
US5082667A (en) * 1988-06-07 1992-01-21 Abbott Laboratories Solid pharmaceutical dosage in tablet triturate form and method of producing same
DE68906461T2 (de) * 1988-06-07 1993-10-21 Abbott Lab Feste Arzneidosis in Form eines Tablettentriturats sowie Verfahren zu deren Herstellung.
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
US5306507A (en) * 1992-03-26 1994-04-26 Mallinckrodt Specialty Chemicals Company Process and composition containing pamabrom and pyrilamine maleate
US5464625A (en) * 1992-05-08 1995-11-07 Monell Chemical Senses Center Non-toxic methods of repelling rodents from materials susceptible to rodent consumption
JPH08510989A (ja) * 1992-10-16 1996-11-19 グラクソ、グループ、リミテッド ラニチジン組成物
KR950703935A (ko) * 1992-11-30 1995-11-17 밋첼 아이, 커시너 맛을 차단하는 약제학적 조성물
WO1997018245A1 (en) * 1995-11-14 1997-05-22 Farmarc Nederland B.V. Complex of naproxen and beta-cyclodextrin
US6214386B1 (en) 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
IT1276160B1 (it) * 1995-11-22 1997-10-27 Recordati Chem Pharm Composizioni farmaceutiche orali a pronto rilascio per sospensioni estemporanee
SE9702338D0 (sv) * 1997-06-18 1997-06-18 Astra Ab An analytical method and industrial process including the same
US7799337B2 (en) * 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US5891476A (en) * 1997-12-22 1999-04-06 Reo; Joe P. Tastemasked pharmaceutical system
US6184220B1 (en) * 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
US6740341B1 (en) 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
JP2002530322A (ja) * 1998-11-25 2002-09-17 シーマ・ラブス・インコーポレイテッド 味隠蔽迅速放出コーティング系
FR2790388B1 (fr) * 1999-03-04 2001-04-13 Synthelabo Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
CN1189159C (zh) 2000-05-05 2005-02-16 欧莱雅 含水溶性美容活性组分水性核的微胶囊及含其的组合物
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
IL164221A0 (en) 2002-04-09 2005-12-18 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim
IL164222A0 (en) 2002-04-09 2005-12-18 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
WO2004004682A2 (en) * 2002-07-02 2004-01-15 Laboratorios S.A.L.V.A.T., S.A. Stable oily suspension of microgranules
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
WO2004108092A2 (en) * 2003-06-05 2004-12-16 P3 Laboratories, Inc. Tannate compositions and methods of use
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
US8473062B2 (en) * 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US9320908B2 (en) * 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US20100185249A1 (en) * 2009-01-22 2010-07-22 Wingeier Brett M Method and Devices for Adrenal Stimulation
GB2529605B (en) * 2014-06-03 2018-03-21 Essential Pharmaceuticals Ltd Pharmaceutical composition
GB201804621D0 (en) * 2018-03-22 2018-05-09 Bcm Specials Ltd Formulation
US20230312842A1 (en) * 2022-02-08 2023-10-05 Fujifilm Business Innovation Corp. Cellulosic particle

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780170A (en) * 1972-07-03 1973-12-18 Warner Lambert Co Tasteless methenamine mandelate
US3879511A (en) * 1972-07-03 1975-04-22 Warner Lambert Co Tasteless methenamine mandelate in a stabilized vegetable oil suspension
ES416148A1 (es) * 1972-12-26 1976-06-01 Willian H Rorer Inc Un procedimiento para preparar particulas antiacidas mejo- radas.
JPS5420572B2 (de) * 1973-04-27 1979-07-24
US4292028A (en) * 1979-07-13 1981-09-29 Arthur Barr Cosmetic breath freshener and palate coolant composition and method of use
NL7908922A (nl) * 1979-12-12 1981-07-16 Akzo Nv Carboximidamide derivaten.
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
SE8404808L (sv) * 1983-10-03 1985-04-04 Avner Rotman Mikrokapslat lekemedel i sot matris
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
JPS6136217A (ja) * 1984-07-27 1986-02-20 Sankyo Co Ltd 経口投与用持効性製剤
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
JPS6317821A (ja) * 1986-07-11 1988-01-25 Taisho Pharmaceut Co Ltd 矯味経口製剤
AU612591B2 (en) * 1986-08-11 1991-07-18 Innovata Biomed Limited Pharmaceutical formulations comprising microcapsules

Also Published As

Publication number Publication date
EP0273890A1 (de) 1988-07-06
JPS63166838A (ja) 1988-07-11
DK668787A (da) 1988-06-23
US5085868A (en) 1992-02-04
HK66396A (en) 1996-04-26
CA1317883C (en) 1993-05-18
FI94923B (fi) 1995-08-15
IE60149B1 (en) 1994-06-15
PH25287A (en) 1991-04-30
ES2039480T3 (es) 1993-10-01
FI875645A (fi) 1988-06-23
EP0273890B1 (de) 1993-03-31
ATE87471T1 (de) 1993-04-15
NO874960L (no) 1988-06-23
IL86607A (en) 1992-03-29
JP2778030B2 (ja) 1998-07-23
DK668787D0 (da) 1987-12-18
FI875645A0 (fi) 1987-12-21
DE3785167D1 (de) 1993-05-06
NO874960D0 (no) 1987-11-27
AU8199187A (en) 1988-06-23
NO177177B (no) 1995-04-24
AU609753B2 (en) 1991-05-09
NO177177C (no) 1995-08-02
FI94923C (fi) 1995-11-27
SE8605515D0 (sv) 1986-12-22
IE873306L (en) 1988-06-22
GR3007542T3 (de) 1993-08-31

Similar Documents

Publication Publication Date Title
DE3785167D1 (de) Eine fluessige verabreichungsform fuer orale verabreichung einer pharmazeutischen substanz.
IT8619675A0 (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale.
AR240250A1 (es) Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo.
IT8767796A0 (it) Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo
DE68915291D1 (de) Verschlusskörpr zur verabreichung einer physiologisch aktiven substanz.
DK583789D0 (da) System til transmucosal indgivelse af den aktive bestanddel af et laegemiddel
DE3682457D1 (de) Geraet zur verabreichung von medikamenten an patienten.
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE69212879T2 (de) Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
ITMI913170A1 (it) Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi
DE69004532T2 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
IT1223343B (it) Formulazioni farmaceutiche per somministrazione transdermica
ES2054089T3 (es) Formulaciones orales liquidas.
IT8722031A0 (it) Formulazioni farmaceutiche e forme di dosaggio per la somministrazione rettale di calcitonina.
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
ATA124091A (de) Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
DK269986A (da) Fremgangsmaade til foroegelse af den transdermale afgivelse af laegemidler samt praeparat til transdermal administrering
MY103532A (en) A liquid dosage form for oral administration of a pharmaceutically active substance
ATA264087A (de) Pharmazeutische praeparate zur oralen verabreichung
FR2577800B1 (fr) Medicament sous forme galenique gastro-resistante
DK202791A (da) Farmaceutisk praeparat med indhold af 3'-azido-3'-desoxythymidin som aktiv ingrediens samt 3'-azido-3'-desoxythymidin til anvendelse mod human retrovirusinfektion
IL81926A0 (en) Pharmaceutical compositions for the oral administration of active proteins
ITMI913248A1 (it) Composizioni terapeutiche adatte per la somministrazione orale contenenti come principio attivo uno o piu' tioesteri del glutatione e procedimento per la preparazione dei suddetti principi attivi
ATE105494T1 (de) Verschlusskoerpr zur verabreichung einer physiologisch aktiven substanz.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition